Mrv1909 03082322382D 22 22 0 0 0 0 999 V2000 1.0716 1.6500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.3572 1.2375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.3572 1.6500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.0716 1.2375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.0716 0.4125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.7861 0.0000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.7861 -0.8250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.5006 -1.2375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.5006 -2.0625 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -3.2151 -2.4750 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 -1.7861 -2.4750 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 -1.0716 -1.2375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.3572 2.4750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.7861 1.2375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2.5006 1.6500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.9703 2.2819 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3.0309 2.2819 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3.2151 1.2375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3.2151 0.4125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2.5006 0.0000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.7861 0.4125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.0716 0.0000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1 2 2 0 0 0 0 2 3 1 0 0 0 0 3 4 2 0 0 0 0 4 5 1 0 0 0 0 5 6 2 0 0 0 0 6 7 1 0 0 0 0 7 8 2 0 0 0 0 8 9 1 0 0 0 0 9 10 1 0 0 0 0 9 11 2 0 0 0 0 7 12 1 0 0 0 0 3 13 1 0 0 0 0 1 14 1 0 0 0 0 14 15 1 0 0 0 0 15 16 1 0 0 0 0 15 17 1 0 0 0 0 15 18 1 0 0 0 0 18 19 1 0 0 0 0 19 20 1 0 0 0 0 20 21 1 0 0 0 0 14 21 2 0 0 0 0 21 22 1 0 0 0 0 M END > DB00523 > drugbank > C\C(\C=C\C1=C(C)CCCC1(C)C)=C\C=C\C(\C)=C\C(O)=O > InChI=1S/C20H28O2/c1-15(8-6-9-16(2)14-19(21)22)11-12-18-17(3)10-7-13-20(18,4)5/h6,8-9,11-12,14H,7,10,13H2,1-5H3,(H,21,22)/b9-6+,12-11+,15-8-,16-14+ > SHGAZHPCJJPHSC-ZVCIMWCZSA-N > C20H28O2 > 300.4351 > 300.20893014 > 2 > 50 > -0.9943172524888088 > 35.906312045798735 > 1 > 1 > 0 > 1 > (2E,4E,6Z,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenoic acid > 5.014367711 > 0 > -1 > 1 > -1 > 4.757033385475081 > 37.3 > 97.7908 > 5 > 0 > 4-amino-N-{1-[(3-chloro-2-fluorophenyl)amino]-6-methylisoquinolin-5-yl}thieno[3,2-d]pyrimidine-7-carboxamide > 1 > DB00523 > APRD00017 > approved; investigational > Alitretinoin > (2E,4E,6Z,8E)-3,7-dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid; (7E,9Z,11E,13E)-retinoic acid; 9-cis-retinoic acid; 9-cis-Tretinoin; 9(Z)-Retinoic acid; Alitretinoin; Alitretinoína; Alitrétinoïne; Alitretinoinum > Clindamycin 1% / Niacinamide 4% / Tretinoin 0.05%; Hanzema; Panretin; Toctino $$$$